Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 07, 2019 07:50 ET | Source: CBT Pharmaceuticals

Apollomics, Inc. (previously CBT Pharmaceuticals, Inc.) Raises $100 Million in Series B Financing

Financing will accelerate development of the Company’s cancer immunotherapy and targeted therapy programs New brand reinforces Apollomics’ mission to discover and develop novel medicines and...
December 10, 2018 07:50 ET | Source: CBT Pharmaceuticals

CBT Pharmaceuticals與Strata Oncology宣佈合作以加快CBT-101的研發。CBT-101是一種高度選擇性的c-Met抑制劑，用於治療非小細胞肺癌及其他實體腫瘤患者

美國加利福尼亞州普萊森頓、中國杭州以及美國密歇根州安娜堡, Dec. 10, 2018 (GLOBE NEWSWIRE) -- CBT Pharmaceuticals (CBT) 是一間在中美兩國均設有辦事處的創新醫藥公司，而Strata...
December 10, 2018 07:50 ET | Source: CBT Pharmaceuticals

CBT Pharmaceuticals和Strata Oncology宣布合作以加快CBT-101的研发。CBT-101是一种高度选择性的c-Met抑制剂，用于治疗非小细胞肺癌及其他实体肿瘤患者

美国加利福尼亚州普莱森顿、中国杭州以及美国密歇根州安娜堡, Dec. 10, 2018 (GLOBE NEWSWIRE) -- CBT Pharmaceuticals (CBT), Inc. 是一家在中美两国均设有总部的创新医药公司，而Strata Oncology, Inc....
December 10, 2018 07:50 ET | Source: CBT Pharmaceuticals

CBT Pharmaceuticals and Strata Oncology Announce Collaboration to Accelerate Development of CBT-101, a c-Met inhibitor, for Patients with Non-Small Cell Lung Cancer and other Solid Tumors

PLEASANTON, Calif., HANGZHOU, China and ANN ARBOR, Mich., Dec. 10, 2018 (GLOBE NEWSWIRE) -- CBT Pharmaceuticals (CBT), Inc., a U.S. and China-based innovative pharmaceutical company, and Strata...
November 26, 2018 07:50 ET | Source: CBT Pharmaceuticals

CBT Pharmaceuticals和Zhejiang Bossan Pharmaceutical簽訂合作和授權協議，共同研發癌症複合療法

美國加州普萊森頓和中國杭州, Nov. 26, 2018 (GLOBE NEWSWIRE) -- CBT Pharmaceuticals（CBT）和Zhejiang Bossan Pharmaceutical Co., Ltd...
November 26, 2018 07:50 ET | Source: CBT Pharmaceuticals

CBT Pharmaceuticals（浙江冠科美博）和浙江博生医药有限公司签订合作和许可协议，共同研发癌症联合疗法

美国加利福尼亚州普莱森顿和中国杭州, Nov. 26, 2018 (GLOBE NEWSWIRE) -- CBT...
November 26, 2018 07:50 ET | Source: CBT Pharmaceuticals

CBT Pharmaceuticals and Zhejiang Bossan Pharmaceutical Enter into a Collaboration and License Agreement to Develop Combination Cancer Treatments

PLEASANTON, Calif. and HANGZHOU, China, Nov. 26, 2018 (GLOBE NEWSWIRE) -- CBT Pharmaceuticals (CBT) and Zhejiang Bossan Pharmaceutical Co., Ltd (Bossan) today announced that they have entered into a...
October 15, 2018 08:50 ET | Source: CBT Pharmaceuticals

CBT的聯用檢查點抑製劑開發項目獲NIH小型企業創新研究撥款

美國加利福尼亞州普萊森頓及中國杭州訊, Oct. 15, 2018 (GLOBE NEWSWIRE) -- CBT...
October 15, 2018 08:50 ET | Source: CBT Pharmaceuticals

CBT的联用检查点抑制剂开发项目获NIH小型企业创新研究拨款

美国加利福尼亚州普莱森顿和中国杭州讯, Oct. 15, 2018 (GLOBE NEWSWIRE) -- CBT Pharmaceuticals (CBT)...
October 15, 2018 08:50 ET | Source: CBT Pharmaceuticals

CBT Pharmaceuticals Awarded NIH Small Business Innovation Research Grant Towards Development of Combination Checkpoint Inhibition

PLEASANTON, Calif. and HANGZHOU, China, Oct. 15, 2018 (GLOBE NEWSWIRE) -- CBT Pharmaceuticals (CBT), a U.S. and China-based innovative biopharmaceutical company committed to becoming a leader in the...